Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • Immune Environment in Glioblastoma (Feb 2023)
    • Korsmeyer Award 25th Anniversary Collection (Jan 2023)
    • Aging (Jul 2022)
    • Next-Generation Sequencing in Medicine (Jun 2022)
    • New Therapeutic Targets in Cardiovascular Diseases (Mar 2022)
    • Immunometabolism (Jan 2022)
    • Circadian Rhythm (Oct 2021)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Commentaries
    • Research letters
    • Letters to the editor
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • In-Press Preview
  • Commentaries
  • Research letters
  • Letters to the editor
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Share this article
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI2006

A targeted point mutation in thrombomodulin generates viable mice with a prethrombotic state.

H Weiler-Guettler, P D Christie, D L Beeler, A M Healy, W W Hancock, H Rayburn, J M Edelberg, and R D Rosenberg

Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA. weiler@brisun.bsew.edu

Find articles by Weiler-Guettler, H. in: JCI | PubMed | Google Scholar

Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA. weiler@brisun.bsew.edu

Find articles by Christie, P. in: JCI | PubMed | Google Scholar

Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA. weiler@brisun.bsew.edu

Find articles by Beeler, D. in: JCI | PubMed | Google Scholar

Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA. weiler@brisun.bsew.edu

Find articles by Healy, A. in: JCI | PubMed | Google Scholar

Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA. weiler@brisun.bsew.edu

Find articles by Hancock, W. in: JCI | PubMed | Google Scholar

Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA. weiler@brisun.bsew.edu

Find articles by Rayburn, H. in: JCI | PubMed | Google Scholar

Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA. weiler@brisun.bsew.edu

Find articles by Edelberg, J. in: JCI | PubMed | Google Scholar

Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA. weiler@brisun.bsew.edu

Find articles by Rosenberg, R. in: JCI | PubMed | Google Scholar

Published May 1, 1998 - More info

Published in Volume 101, Issue 9 on May 1, 1998
J Clin Invest. 1998;101(9):1983–1991. https://doi.org/10.1172/JCI2006.
© 1998 The American Society for Clinical Investigation
Published May 1, 1998 - Version history
View PDF
Abstract

The activity of the coagulation system is regulated, in part, by the interaction of thrombin with the endothelial cell receptor thrombomodulin with subsequent generation of activated protein C and suppression of thrombin production. Our previous investigation demonstrated that ablation of the thrombomodulin gene in mice causes embryonic lethality before the assembly of a functional cardiovascular system, indicating a critical role for the receptor in early development. In the current study, we show that a single amino acid substitution in thrombomodulin dissociates the developmental function of the receptor from its role as a regulator of blood coagulation. Homozygous mutant mice with severely reduced capacity to generate activated protein C or inhibit thrombin develop to term, and possess normal reproductive performance. The above animals exhibit increased fibrin deposition in selected organs, which implies tissue specific regulation of the coagulation system that is supported by further evidence from the examination of mice with defects in fibrinolysis. The thrombomodulin-deficient animals provide a murine model to examine known or identify unknown genetic and environmental factors that lead to the development of thrombosis.

Version history
  • Version 1 (May 1, 1998): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Share this article
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2023 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts